Marvell's Google Pact: A $120 Billion Ceiling With a Built-In Dilution Clause

Marvell stock jumps 16% after Google expands custom-chip pact, with equity warrants vesting only if purchases hit $120B by 2033.

The market's reaction to Marvell Technology's expanded custom-chip agreement with Google was swift and unambiguous — shares climbed roughly 10 percent on Wednesday before adding another 5.7 percent on Thursday to close at 215.00 euros. The two-day surge, which leaves the stock up 16 percent over the past month, reflects a deal that analysts describe as the most consequential development for the chipmaker in years.

But beneath the headline numbers lies a contract engineered with unusual precision, one that ties Google's equity stake directly to how much silicon it actually buys.

The Mechanics Behind the Milestone

Under the terms of the expanded partnership, Marvell will develop custom chips spanning Google's entire TPU ecosystem — from AI accelerators to memory and networking silicon. In exchange, Google receives a warrant covering up to 58.97 million Marvell shares at an exercise price of $206.58, a position currently in the money and valued at roughly $12.2 billion.

The vesting schedule is where the deal gets interesting. The warrant unlocks in 240 tranches, each tied to $500 million in cumulative custom-product purchases, with the full amount vesting only if Google's orders reach $120 billion by the fiscal year 2033. That structure matters: this is a revenue commitment, not a guarantee, as several analysts were quick to note. Investors tracking the vesting milestones can read Google's seriousness about custom silicon directly from the numbers.

Full exercise would hand Google approximately 7 percent of Marvell's equity — a dilution that some market participants argue is getting lost in the euphoria. Every additional dollar of custom revenue will, from that point forward, be shared proportionally with Google as tranches vest.

Wall Street's Widening Divide

The analyst community has responded with anything but unanimity. JPMorgan reaffirmed its Overweight rating with a $240 price target, projecting roughly $19.2 billion in annual revenue from the deal at full execution. Barclays went further, setting a $275 target and estimating a potential earnings contribution of $6.15 per share based on a 35 percent margin. UBS raised its target to $310, while BMO, Raymond James, and Wells Fargo all weighed in positively.

Yet the bull case is far from universal. KeyBanc sees the stock at $400, while Morgan Stanley's fair-value estimate sits at just $195. RBC Capital confirmed its $360 target with an Outperform rating on Thursday, and Roth and Jefferies lifted their targets to $350 and $325 respectively. At the other end of the spectrum, a Seeking Alpha analyst dismissed what he called the "trillion-dollar narrative" around Marvell as overblown, calling the current valuation unattractive.

The skepticism has a factual basis. Depending on the source, the stock trades at 38 to 74 times forward earnings — a multiple that suggests the market has already priced in a substantial portion of revenue that won't materialize for years.

Broadcom's Setback and the Bigger Picture

The announcement landed as a direct hit on Broadcom, whose shares fell as much as 5 percent on the day as investors digested the prospect of a serious rival in Google's custom-chip business. Broadcom CEO Hock Tan pushed back, noting his company remains the central partner for Google's Tensor Processing Units through 2031 and projecting AI revenue above $100 billion for fiscal 2027. Bernstein analysts framed the situation more constructively: the overall AI chip market is expanding, and both suppliers could benefit.

The Numbers Behind the Story

Marvell's operational momentum is real. First-quarter revenue grew 28 percent year over year to $2.418 billion, with the data center business now accounting for 76 percent of sales. The company has guided to second-quarter revenue of approximately $2.7 billion — a 35 percent increase — with earnings per share of $0.93 expected. Jefferies anticipates a "beat and raise" when Marvell reports on August 27, a date that now carries outsized significance given the elevated expectations.

The stock's trajectory tells its own story. Up 195 percent since the start of the year and trading about 4.9 percent above its 50-day moving average, Marvell retains clear momentum. Yet it remains roughly 26 percent below its 52-week high of 290.35 euros, reached as recently as June — a reminder that the market has previously valued the company more generously and then pulled back.

For investors, the calculus comes down to a single question: how much of the $120 billion opportunity will actually flow to existing shareholders after the warrant vests? The answer will determine whether Thursday's close of 215.00 euros looks like a starting point or a peak.